FDA Reportedly Shelves Commissioner's National Priority Voucher Program

The FDA has reportedly halted new awards under the Commissioner's National Priority Voucher program, which aimed to accelerate drug approvals hitting key national health priorities, though HHS states the pilot remains ongoing. The program expedited approvals for 12 drugs including Wegovy HD and Otarmeni but recent approvals have bypassed the program's executive review council, creating uncertainty around its future.

This Wire brief sits within Fusion42's coverage of Health, and 2 sources have reported it.